Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?

Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M.

Liver Transpl. 2010 Aug;16(8):964-73. doi: 10.1002/lt.22093.

2.

Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.

Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.

J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.

PMID:
19686416
4.

Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.

Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.

Liver Transpl. 2008 Jun;14(6):837-44. doi: 10.1002/lt.21439.

5.
6.

A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.

Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M.

Liver Int. 2015 Jan;35(1):184-91. doi: 10.1111/liv.12538. Epub 2014 Apr 8.

PMID:
24650058
7.
8.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

9.

Which score system can best predict recipient outcomes after living donor liver transplantation?

Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK.

Transplant Proc. 2012 Mar;44(2):393-5. doi: 10.1016/j.transproceed.2012.01.064.

PMID:
22410025
10.

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.

Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.

Am J Gastroenterol. 2002 Nov;97(11):2855-60.

PMID:
12425560
11.

Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.

Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.

J Clin Gastroenterol. 2007 Aug;41(7):706-12.

PMID:
17667056
12.

A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.

Hassan EA, Abd El-Rehim AS.

Arab J Gastroenterol. 2013 Dec;14(4):158-64. doi: 10.1016/j.ajg.2013.08.007. Epub 2013 Sep 29.

PMID:
24433645
13.

Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation.

Degré D, Bourgeois N, Boon N, Le Moine O, Louis H, Donckier V, El Nakadi I, Closset J, Lingier P, Vereerstraeten P, Gelin M, Adler M.

Transpl Int. 2004 Jan;17(1):31-8. Epub 2003 Sep 11.

14.

MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.

Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC; Liver Transplantation Group.

Clin Transplant. 2012 Jul-Aug;26(4):E395-401. doi: 10.1111/j.1399-0012.2012.01688.x.

PMID:
22882694
15.

Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction.

Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.

Transplantation. 2005 Nov 27;80(10):1414-8.

PMID:
16340784
16.

Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.

Mishra P, Desai N, Alexander J, Singh DP, Sawant P.

J Gastroenterol Hepatol. 2007 Aug;22(8):1232-5.

PMID:
17688663
17.

Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.

Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS.

Clin Invest Med. 2004 Aug;27(4):162-7.

PMID:
15453152
18.

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.

Liver Int. 2004 Oct;24(5):465-70.

PMID:
15482344
19.

Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.

Costa BP, Sousa FC, Serôdio M, Carvalho C.

World J Surg. 2009 Aug;33(8):1711-9. doi: 10.1007/s00268-009-0093-4.

PMID:
19513784
20.

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD.

Liver Transpl. 2006 Jun;12(6):966-71.

Supplemental Content

Support Center